Generate a tailored SOP for Dr. Clive Page. Improve your application with a focused, well-structured draft.
Clive Page is a Professor of Pharmacology at King’s College London and the Director of the Pulmonary Pharmacology Unit. He has made significant contributions to the field of pharmacology, particularly in the area of respiratory disease, having published over 250 scientific papers. Clive is also a co-founder and Chairman of the Board at Verona Pharma plc, a company focused on developing new treatments for Respiratory Diseases. Additionally, he serves as a Non-Executive Director for Babraham Biotechnology Ltd and ImmunoRegulation Ltd. He has previously held Board positions with Cardiome Canada and Stirling Products Ltd in Australia. Clive's early career began in the pharmaceutical industry with Sandoz Ltd in Basel, Switzerland, where he gained experience that has informed his extensive consulting role with the pharmaceutical and biotech sectors. His research interests primarily focus on pharmacology, inflammation, and respiratory disease, contributing to various public discussions on the use of animals in research. Clive was awarded the Society of Biology President's Medal in 2012 for his outstanding contributions to the life sciences and was made a Fellow of the Royal Society of Biology. In 2017, he received an OBE for his services to pharmacology.
Pulmonary Pharmacology Unit, King's College London • London, ENG, GB
Leading research efforts in understanding and treating respiratory diseases.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.